| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c190c99174dfe46deef72ae3ad792590 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 |
| filingDate |
2016-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a29135d1745d53e4013851db7f83d490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd8151c4ac42eaeca4329955df889357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_751deeaef4f7e454ed434a547f24a137 |
| publicationDate |
2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017181377-A |
| titleOfInvention |
Measurement error reduction method in latex immunoaggregation |
| abstract |
An object of the present invention is to avoid the influence of measurement error derived from a blood sample in latex immunoagglutination. In a liquid phase, in the presence of imidazole, a measurement error derived from a blood sample in a latex immunoagglutination method by contacting the sample with latex particles carrying a specific affinity substance for the substance to be measured. Was able to be reduced. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019064491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11668708-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022163605-A1 |
| priorityDate |
2016-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |